FDA NeuroBloc coverage for business development, investment, and market access teams
NeuroBloc has received FDA approval as a non-opioid treatment for chronic neuropathic pain, providing an innovative alternative for pain relief.
We use cookies to enhance your experience, analyze traffic, and for marketing. By continuing to use our site, you consent to our use of cookies. Privacy Policy
